(0.26%) 5 474.80 points
(0.16%) 39 180 points
(0.75%) 17 866 points
(2.18%) $83.32
(-4.08%) $2.50
(-0.06%) $2 338.10
(1.10%) $29.56
(-1.24%) $989.50
(-0.10%) $0.932
(-0.05%) $10.67
(0.09%) $0.791
(1.05%) $86.63
@ $69.20
Utstedt: 1 jul 2024 @ 16:30
Avkastning: -100.00%
Forrige signal: jul 1 - 15:48
Forrige signal:
Avkastning: -1.44 %
Live Chart Being Loaded With Signals
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States...
Stats | |
---|---|
Dagens volum | 0 |
Gjennomsnittsvolum | 0 |
Markedsverdi | 0 |
EPS | $-0.160 ( Q1 | 2024-05-07 ) |
Neste inntjeningsdato | ( $-0.200 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 0 |
ATR14 | $5.21 (7.82%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-23 | Van Nostrand Robert L | Buy | 1 567 | Common Stock |
2024-06-23 | Van Nostrand Robert L | Sell | 1 567 | Restricted Stock Units |
2024-06-23 | Salas Eduardo Rene | Buy | 1 567 | Common Stock |
2024-06-23 | Salas Eduardo Rene | Sell | 1 567 | Restricted Stock Units |
2024-06-23 | Marcus Joel S | Buy | 1 567 | Common Stock |
INSIDER POWER |
---|
6.03 |
Last 100 transactions |
Buy: 523 231 | Sell: 460 908 |
Volum Korrelasjon
Intra-Cellular Therapies Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Intra-Cellular Therapies Korrelasjon - Valuta/Råvare
Intra-Cellular Therapies Økonomi
Annual | 2023 |
Omsetning: | $462.18M |
Bruttogevinst: | $428.43M (92.70 %) |
EPS: | $-1.460 |
FY | 2023 |
Omsetning: | $462.18M |
Bruttogevinst: | $428.43M (92.70 %) |
EPS: | $-1.460 |
FY | 2022 |
Omsetning: | $249.13M |
Bruttogevinst: | $228.69M (91.79 %) |
EPS: | $-2.72 |
FY | 2021 |
Omsetning: | $83.80M |
Bruttogevinst: | $75.77M (90.41 %) |
EPS: | $-3.50 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Intra-Cellular Therapies
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.